Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Albireo
Biotech
Albireo CMO Horn exits 5 months after US, EU approvals
FDA, Europe approvals of Albireo's rare liver disease drug wasn't enough to keep Chief Medical Officer Pat Horn. Co-founder will hold interim duties.
Kyle LaHucik
Dec 9, 2021 3:40pm
Albireo drops fatty liver program after ‘unremarkable results’
Aug 18, 2020 10:02pm
Chutes & Ladders—Gilead's 2 top executives step down
Jul 27, 2018 8:00am
